Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Accuitis, Inc.
Yale researchers call on FDA to send more pre-notices of noncompliance to those who have not reported trial results. Of 58 pre-notices in last eight years, 56% went to pharma industry and none went to federal agencies. Commissioner-in-waiting Califf is expected to focus on trial reporting.